Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1984:73 Suppl 2:95-9.

Calcium antagonists, firstline partners for betablockers in hypertension

  • PMID: 6152093
Clinical Trial

Calcium antagonists, firstline partners for betablockers in hypertension

F R Bühler. Z Kardiol. 1984.

Abstract

Monotherapy with the calcium antagonists verapamil, nifedipine, nitrendipine or diltiazem was shown to have a good efficacy/tolerability ratio in the treatment of patients with essential hypertension and overall blood pressure responses were comparable as well as similar to those observed with betablockers and diuretics. The antihypertensive effects of the calcium antagonists were directly related to the patient's age, pretreatment blood pressure but indirectly to pretreatment renin. In intraindividual comparisons, antihypertensive responses with verapamil related directly to those obtained with diuretics but indirectly to those seen with betablocker monotherapy. Accordingly, calcium antagonists can be used as first line drugs particularly in older and low renin patients, to a large extent in place of a diuretic, while a betablocker is used primarily for the younger and high renin patients. This concept does not devalue the diuretics, but it may change the order to their use in treatment plan that is oriented towards cardioprotection.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources